Phase 2 Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 21 and 80 years old (inclusive)
- Your kidneys are working at a reduced but not completely failed level, based on a specific kidney function test result (eGFR between 15 and 75)
- A urine test shows a certain level of protein leaking into your urine (albumin-to-creatinine ratio above 30 mg/g)
- If your urine protein level is higher (above 300 mg/g), you are already taking the highest dose of a blood pressure/kidney-protecting medication you can tolerate (an ACE inhibitor or ARB)
- If your doctor recommends it, you are already taking a type of diabetes/kidney medication called an SGLT-2 inhibitor
- You are willing and able to sign a consent form and follow the study plan
Who may not be able to join:
- You have had a bad reaction or allergy to colchicine in the past
- You were in the hospital for any reason in the last 30 days
- You have an urgent medical condition that needs immediate treatment right now
- You have moderate or advanced heart failure (Stage C or D)
- Your heart is pumping less than 40% of its normal capacity
- You have heart valve disease that is causing symptoms
- You were born with a heart defect, whether or not it has been repaired
- You have previously had a heart transplant
- Your kidneys have completely failed, meaning you have had a kidney transplant or you are on dialysis (hemodialysis or peritoneal dialysis)
- Your kidney function has gotten significantly worse in the last 30 days or the last 7 days
- You have taken anti-inflammatory or immune-suppressing medications in the last 30 days (with some limited exceptions for short-term use — confirm with trial site)
- You have Familial Mediterranean Fever, a gout flare within the last 12 months, pericarditis, or another condition that would normally be treated with colchicine
- You have taken antibiotics or other antimicrobial medicines in the last 30 days, or you currently have an active infection
- You have a history of breathing or lung problems that a doctor believes could raise your risk of pneumonia
- You had surgery in the last 30 days, or you have surgery planned during the study period
- You currently have cancer, or you have been treated for cancer within the last year
- A doctor believes that your overall health or life expectancy due to serious illness would make participation too risky
- Your white blood cell (neutrophil) count is too low, based on a blood test
- Your platelet count is too low, based on a blood test
- You are taking certain medications that can interact dangerously with colchicine, such as cyclosporine, clarithromycin, diltiazem, verapamil, itraconazole, ritonavir, digoxin, or others — including regular grapefruit juice (confirm with trial site)
- You are taking certain cholesterol or fat-lowering medications (such as simvastatin, gemfibrozil, or fenofibrate), or a blood test shows your muscle enzyme levels are too high
- You have moderate or severe liver disease
- You are pregnant, breastfeeding, or are unwilling or unable to use appropriate contraception during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Leo F Buckley, PharmD MPH, Brigham and Women's Hospital
Phone: 617-732-5500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Between-group change in left ventricular global longitudinal strain
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.